Single IRB workflows can reduce duplicated review, but research sites still need clear local responsibilities, reliance documentation, consent version control, and communication paths.
In this guide
Key points
- Single IRB readiness is operational, not only regulatory.
- Sites should separate central IRB review from local institutional approvals and ancillary steps.
- Coordinator training should cover approved documents, reporting paths, consent versions, and local context requirements.
Single IRB readiness is operational
For many multisite studies, a single Institutional Review Board model can reduce duplicated review and create a more consistent oversight process.
NIH policy generally expects a single IRB for domestic sites in NIH-funded multisite research involving non-exempt human subjects research. For sites, the practical question is not only who the IRB is. It is whether the site is operationally ready to work under that model.
Confirm roles early
Know which IRB is reviewing the study, which institutions are relying on that review, who owns local context updates, and who handles communication between the site, sponsor, coordinating center, and IRB.
The readiness checklist should name the local owner for every dependency. Reliance agreements, local context language, ancillary reviews, training confirmations, and site activation notes should not live only in email threads.
Sites should also identify which local steps remain required. Even under a single IRB, a site may still need institutional sign-off, conflict-of-interest review, ancillary committee review, training confirmation, or other local approvals.
Prepare reliance and consent workflows
Reliance documentation should be tracked before activation pressure begins. Teams need to know whether agreements, institutional approvals, and local sign-offs are complete.
Consent version control also needs attention. A site should be able to prove which consent version was approved, which version is active, how staff are alerted when a version changes, and whether recruitment materials need the same update.
Use a case-study lens
A multisite study launches with central IRB approval, but one site delays activation because local ancillary review was not started. The issue is not the single IRB model itself. The issue is that local steps were invisible until the launch timeline was already compressed.
A better site activation checklist separates central IRB review from local institutional steps and assigns an owner to each dependency.
Turn readiness into activation checks
Before patient outreach begins, the site should confirm active consent documents, approved recruitment language, local contacts, escalation paths, staff training, and any sponsor or coordinating-center instructions that affect patient-facing workflow.
That checklist should be reviewed again when a document version changes. A single IRB workflow can still create local execution risk if coordinators do not know which materials are current or who approves the next change.
Where TrialsNest fits
TrialsNest is not an IRB system, but recruitment teams still benefit when study activation dependencies, site readiness notes, document status, coordinator tasks, and patient-facing workflow steps are visible together.
The goal is to prevent enrollment operations from assuming a site is ready before the required review, documentation, training, and local activation steps are complete and current.
Sources used for this checklist
NIH Single IRB Policy for Multi-Site Research explains the policy context for many domestic multisite research studies: https://grants.nih.gov/policy-and-compliance/policy-topics/single-irb-policy-multi-site-research
HHS OHRP IRBs and Assurances guidance explains registration and assurance context for human-subjects research oversight: https://www.hhs.gov/ohrp/register-irbs-and-obtain-fwas/index.html
Sources and editorial notes
Published .
This guide explains recruitment work and questions to discuss with your team.
This information is educational. Your study team makes medical, eligibility, and enrollment decisions.
See TrialsNest in action
Bring this workflow into one place.
Manage inquiries, follow-ups, records, and visits. Keep sponsors updated on progress.
Coordinator Today
Your inquiries, priorities, and upcoming visits.
- Inquiries assigned
- 14 3 pending review
- Visits today
- 6 4 in person · 2 virtual
- Action priorities
- 4 Needs attention
- Active studies
- 3 Study A · B · C
Priority tasks
- Review screening intakeInquiry 001 · Study ACompleted
- Verify specimen preparationStudy A · Due 10:00 AMCompleted
- Confirm visit windowInquiry 003 · Follow-upPending
Upcoming visits
- In personInquiry 001
Study A · Baseline visit
View visit details → - TelehealthInquiry 003
Study A · Prescreen
Review appointment → - In personInquiry 004
Study B · Week 4
View visit details →
Keep reading
Clinical trial consent visit prep checklist for research sites
A consent visit prep checklist for sites coordinating records, visit logistics, participant questions, and review boundaries.
eConsent rollout checklist for clinical trial sites
An eConsent rollout checklist for clinical trial sites coordinating patient expectations, training, delegation, records, and visit readiness.
Site recruitment workflow for clinical trials
See the site recruitment workflow for clinical trials, from patient intake and records readiness to patient recruitment tracking dashboards, scheduling, and sponsor updates.
Clinical trial regulatory binder checklist for recruitment operations
Recruitment operations should stay aligned with regulatory binder expectations for approved materials, source documentation, delegation, training, and version control.
